HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nutraquest bankruptcy

This article was originally published in The Tan Sheet

Executive Summary

Manasquan, N.J.-based firm, formerly known as Cytodyne Technologies, estimates its debt at between $50 mil. and $100 mil. and assets at $10 mil. to $50 mil. in Oct. 16 Chapter 11 filing. Filing puts federal and state lawsuits related to Cytodyne's ephedra-containing and ephedra-free Xenadrine products, including a hold on wrongful death suit filed by widow of Orioles pitcher Steve Bechler (1"The Tan Sheet" July 21, 2003, p. 3). Cytodyne President Robert Chinery formed Nutraquest in June when Cytodyne licensed rights to all its products to Xenadrine manufacturer Phoenix Labs (2"The Tan Sheet" June 23, 2003, p. 13)...

You may also be interested in...

Xenadrine Safety Misrepresentations Alleged In Bechler Suit v. Cytodyne

Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16

Cytodyne Products’ Distribution And Sales Rights Licensed To Phoenix Labs

Cytodyne Technologies has licensed the distribution, marketing and sales rights to its products to Apex Fitness Group's Phoenix Labs division, the firms announced June 16

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts